Comparison between Maxposure IPO and Qualitek Labs IPO.
Maxposure IPO is a SME Fixed Price IPO proposed to list at NSE SME while Qualitek Labs IPO is a SME Fixed Price proposed to list at BSE SME.
| Maxposure IPO | Qualitek Labs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | GYR Capital Advisors Pvt.Ltd. | Oneview Corporate Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Giriraj Stock Broking Pvt.Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Maxposure IPO is up to ₹19.03 Cr whereas the issue size of the Qualitek Labs IPO is up to ₹18.65 Cr. The final issue price of Maxposure IPO is ₹33.00 per share and of Qualitek Labs IPO is ₹100.00 per share.
| Maxposure IPO | Qualitek Labs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹31.00 per share | |
| Issue Price (Upper) | ₹33.00 per share | |
| Issue Price (Final) | ₹33.00 per share | ₹100.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 1200 shares |
| Fresh Issue Size | 57,68,000 shares | 18,64,800 shares |
| Fresh Issue Size (Amount) | up to ₹19.03 Cr | up to ₹18.65 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,68,000 shares | 18,64,800 shares |
| Issue Size Total (Amount) | up to ₹19.03 Cr | up to ₹18.65 Cr |
Maxposure IPO opens on Jan 15, 2024, while Qualitek Labs IPO opens on Jan 18, 2024. The closing date of Maxposure IPO and Qualitek Labs IPO is Jan 17, 2024, and Jan 23, 2024, respectively.
| Maxposure IPO | Qualitek Labs IPO | |
|---|---|---|
| Anchor Bid Date | Jan 12, 2024 | |
| Issue Open | Jan 15, 2024 | Jan 18, 2024 |
| Issue Close | Jan 17, 2024 | Jan 23, 2024 |
| Basis Of Allotment (Tentative) | Jan 18, 2024 | Jan 24, 2024 |
| Initiation of Refunds (Tentative) | Jan 19, 2024 | Jan 25, 2024 |
| Credit of Share (Tentative) | Jan 19, 2024 | Jan 25, 2024 |
| Listing date (Tentative) | Jan 23, 2024 | Jan 29, 2024 |
| Anchor Lockin End date 1 | Feb 17, 2024 | |
| Anchor Lockin End date 2 | Apr 17, 2024 |
Maxposure IPO P/E ratio is 12.42, as compared to Qualitek Labs IPO P/E ratio of 18.21.
| Maxposure IPO | Qualitek Labs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Maxposure Limited Financial Information (Restated)Maxposure Limited's revenue increased by 1.03% and profit after tax (PAT) rose by 1162.04% between the financial year ending with March 31, 2023 and March 31, 2022.
| Qualitek Labs Limited Financial Information (Restated Standalone)Qualitek Labs Limited's revenue increased by 61.03% and profit after tax (PAT) rose by 161.43% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 84.35 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.58 | 73.35 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.42 | 18.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹75.05 Cr. | ₹73.72 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 14.39% | 50.49% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 19.55% | 13.76% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.66 | ₹5.49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 14.20% | 30.10% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Maxposure IPO Retail Individual Investors (RII) are offered 20,48,000 shares while in Qualitek Labs IPO retail investors are offered 20,48,000 shares. Qualified Institutional Buyers (QIB) are offered 11,40,000 shares in Maxposure IPO and in Qualitek Labs IPO.
| Maxposure IPO | Qualitek Labs IPO | |
|---|---|---|
| Anchor Investor Reserveration | 17,00,000 shares | |
| Market Maker Reserveration | 3,72,000 shares | 99,600 shares |
| QIB | 11,40,000 shares | |
| NII | 8,80,000 shares | 9,32,400 shares |
| RII | 20,48,000 shares | 9,32,400 shares |
| Employee | ||
| Others | ||
| Total | 57,68,000 shares | 18,64,800 shares |
Maxposure IPO subscribed 987.47x in total, whereas Qualitek Labs IPO subscribed 58.95x.
| Maxposure IPO | Qualitek Labs IPO | |
|---|---|---|
| QIB (times) | 162.35x | |
| NII (times) | 1,947.55x | 69.37x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1,034.23x | 39.23x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 987.47x | 58.95x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
